Consistent with the in vitro data, in SLC2A3-overexpressing OCI-LY1 xenograft models, the combination of 5-azacytidine and vitamin C significantly improved the tumor-suppressive effect of cisplatin compared with that in empty vector-transduced OCI-LY1 xenograft models (Fig. 7H–J). Here, SLC2A3 is linked to neoplasm.